Recent Advance in Osteoclastogenesis Inhibitory Factor
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Osteoclastogenesis inhibitory factor or osteoprotegerin(OPG/OCIF) is a novel secreted glycoprotein involved in the regulation of bone density. It is a novel member of the TNF receptor superfamily. Mature OPG/OCIF contains 7 domains and can be divided into 3 regions(TNF receptor cysteine-rich region; death domain region and heperin binding region). The OPG/OCIF gene is a single-copy gene consisting of five exons and four introns. It is located in 8q23~24. The factors involved in the regulation of bone formation and resoption(eg. TGF-β1,1,25(OH)2VD3 and TNF-α)regulate the expression of OPG/OCIF gene. The mechanisms by which OPG/OCIF inhibits bone resoption can be concluded that: 1) OPG/OCIF inhibits survival of osteoclasts and induces apoptosis of osteoclasts; 2) OPG/OCIF inhibits formation of osteoclasts.

    Reference
    Related
    Cited by
Get Citation

HE Zhi-Yong, LI Ming-Feng, ZHANG Wei-Jie, WU Xiang-Fu. Recent Advance in Osteoclastogenesis Inhibitory Factor[J]. Progress in Biochemistry and Biophysics,2000,27(5):469-472

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 30,1999
  • Revised:February 21,2000
  • Accepted:
  • Online:
  • Published: